Natural Product: NPC474265

Natural Product IDNPC474265
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Bryonioside B
IUPAC Name (3S,8S,9R,10R,13R,14S,17R)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one
Synonyms bryonioside B
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL464459
PubChem CID 10865639
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001013] Steroidal glycosides
          • [CHEMONTID:0002364] Steroidal saponins
            • [CHEMONTID:0001687] Cucurbitacin glycosides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BQYXEGPEDSNOPN-UEOQDMPUSA-N
Standard InCHI InChI=1S/C42H70O13/c1-20(10-14-27(44)39(5,6)51)22-16-17-40(7)26-13-11-23-24(42(26,9)28(45)18-41(22,40)8)12-15-29(38(23,3)4)54-37-35(33(49)31(47)25(19-43)53-37)55-36-34(50)32(48)30(46)21(2)52-36/h11,20-22,24-27,29-37,43-44,46-51H,10,12-19H2,1-9H3/t20-,21+,22-,24-,25-,26+,27-,29+,30+,31-,32-,33+,34-,35-,36+,37+,40+,41-,42+/m1/s1
SMILES CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CCC4C(=CCC5C4(C(=O)CC6(C5(CCC6C(C)CCC(C(C)(C)O)O)C)C)C)C3(C)C)CO)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   782.48 Volume:   792.649
?
Van der Waals volume.
Dense:   0.987 LogP:   2.045
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.908
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.779
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   10.0 Rigid Bonds:   33.0
TPSA:   215.83
?
Topological Polar Surface Area.
H-Bond Acceptor:   13.0
H-Bond Donor:   8.0 Rings:   6.0
Heavy Atoms:   13.0

MedChem Properties

QED Drug-Likeness Score:   0.15 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.951 Fsp3:   0.929
MCE-18:   132.222
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.066 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.008
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.197
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.166 Promiscuous compounds:   0.002

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.991 MDCK Permeability:   -5.085
Pgp-inhibitor:   0.0 Pgp-substrate:   0.919
PAMPA:   0.998
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.088
20% Bioavailability (F20%):   0.002 30% Bioavailability (F30%):   0.366
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.303 MRP1:   1.0
Plasma Protein Binding (PPB):   65.826% Volume Distribution (VD):   -0.372
Fu: 24.419%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.0
OATP1B3 inhibitor:   0.921 BCRP inhibitor:   0.025
BSEP inhibitor:   0.349

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.999 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.489 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.001
CYP3A4-inhibitor:   0.993 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.002 CYP2C8-inhibitor:   0.99
HLM stability:   0.004
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.079 Half-life (T1/2):  2.91

ADMET: Toxicity

hERG Blockers:  0.047 hERG Blockers (10um):  0.337
Human Hepatotoxicity (H-HT):  0.578 Drug-induced Liver Injury (DILI):  0.205
AMES Toxicity:  0.27 Rat Oral Acute Toxicity:  0.147
Maximum Recommended Daily Dose:  0.505 Skin Sensitization:  0.135
Carcinogencity:  0.067 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.019
Drug-induced Neurotoxicity:  0.491 Ototoxicity:  0.998
Hematotoxicity:  0.046 Drug-induced Nephrotoxicity:  0.08
Genotoxicity:  0.092 RPMI-8226 Immunitoxicity:  0.089
A549 Cytotoxicity:  0.109 Hek293 Cytotoxicity:  0.69
BCF:   0.894
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.85
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.71
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.24
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33132 bryonia dioica Species Cucurbitaceae Eukaryota Roots n.a. n.a. PMID[11858752]
NPO33132 bryonia dioica Species Cucurbitaceae Eukaryota n.a. n.a. n.a. PMID[17503850]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell line Raji Homo sapiens Activity = 60.0 % PubChem BioAssay data set
NPT2 Others Unspecified n.a. Inhibition = 0.0 % PMID[22037378]
NPT2 Others Unspecified n.a. Inhibition = 29.9 % PMID[25729554]
NPT2 Others Unspecified n.a. Inhibition = 72.7 % PubChem BioAssay data set
NPT2 Others Unspecified n.a. Inhibition = 97.4 % DOI[10.6019/CHEMBL1201861]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus ID50 = 0.2 mg PMID[2853205]
NPT32 Organism Mus musculus Mus musculus Activity = 94.0 % PMID[2853205]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC474265 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8736 High Similarity NPC474557
0.8193 Intermediate Similarity NPC154856
0.8132 Intermediate Similarity NPC473882
0.8068 Intermediate Similarity NPC485578
0.7396 Intermediate Similarity NPC485579
0.7079 Intermediate Similarity NPC130427
0.6889 Remote Similarity NPC74727
0.6771 Remote Similarity NPC279638
0.6735 Remote Similarity NPC168899
0.6735 Remote Similarity NPC69273
0.6731 Remote Similarity NPC485580
0.5909 Remote Similarity NPC241008
0.5865 Remote Similarity NPC302057
0.5686 Remote Similarity NPC210420
0.5625 Remote Similarity NPC34562
0.5625 Remote Similarity NPC52241
0.5521 Remote Similarity NPC221562
0.5472 Remote Similarity NPC293623
0.5392 Remote Similarity NPC309448
0.534 Remote Similarity NPC485581
0.5306 Remote Similarity NPC187400
0.5288 Remote Similarity NPC190395
0.5258 Remote Similarity NPC75608
0.5227 Remote Similarity NPC32830
0.5179 Remote Similarity NPC162574
0.51 Remote Similarity NPC475317
0.5045 Remote Similarity NPC485582

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474265 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data